26 results on '"Etra, Aaron"'
Search Results
2. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
5. A Day 14 Endpoint for Acute GVHD Clinical Trials
6. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
7. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
8. Effective treatment of low-risk acute GVHD with itacitinib monotherapy
9. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
10. Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee
11. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
12. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
13. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
14. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
15. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
16. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
17. Death of Woman with peripartum influenza B virus infection and necrotizing pneumonia
18. Bulletin
19. Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease.
20. 274 AUTOLOGOUS STEM CELL TRANSPLANT MAY "RESET" NOT ONLY THE IMMUNE SYSTEM BUT MICROBIOME STRUCTURE AND FUNCTION IN PATIENTS WITH CROHN'S DISEASE.
21. Mo1537: COMBINATION AUTOLOGOUS STEM CELL TRANSPLANTATION AND VEDOLIZUMAB FOR REFRACTORY CROHN'S DISEASE.
22. P-063: Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma.
23. Insights from the Front Lines of Nutraceutical Research: The Third International Conference on Mechanisms of Action of Nutraceuticals (ICMAN 3).
24. Comparison of Gvhd Biomarker Algorithms for Predicting Lethal Gvhd and Non-Relapse Mortality.
25. Tu2029 Recent Causes of Hepatocellular Carcinoma in a U.S. Urban Medical Center.
26. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.